Detalhe da pesquisa
1.
Higher body fat percentage is associated with enhanced temperature perception in NAFLD: results from the randomised Wessex Evaluation of fatty Liver and Cardiovascular markers in NAFLD with OMacor thErapy trial (WELCOME) trial.
Diabetologia
; 59(7): 1422-1429, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27106721
2.
Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial.
Diabetologia
; 58(8): 1916-25, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26021488
3.
Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.
J Hepatol
; 63(6): 1476-83, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26272871
4.
Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.
Hepatology
; 60(4): 1211-21, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043514